A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children

Completed · Phase 1

Conditions studied: Herpes Simplex

In brief

Limited data are available on valaciclovir use in children and valaciclovir is not currently approved for use in pediatrics. The marketed formulation of valaciclovir is not ideal for use in pre-adolescent patients who may have trouble swallowing solid oral dosage forms. An extemporaneous suspension formulation of valaciclovir has been developed to expedite the provision of benefits to children similar to those from administration of valaciclovir solid formulations in adults.

Key facts

Study ID
NCT00297206
Run by
GlaxoSmithKline
People needed
36
Starts
2003-01-25
Expected to finish
2007-02-28
Last updated by the study team
2017-09-11

Who can join

Age: 0 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.